Glucocorticoid effects on the skeletal muscle differentiation program: analysis of clonal proliferation, morphological differentiation and the expression of muscle-specific and regulatory genes

Endocr Res. 1997 Feb-May;23(1-2):37-57. doi: 10.1080/07435809709031841.

Abstract

We examined the effect of glucocorticoids on the proliferation and differentiation of skeletal muscle cells using the C2C12 cell line. We found that treatment with glucocorticoids enhanced muscle cell differentiation but had only minor effects on the clonal growth rate of C2C12 cells. The stimulatory effect of glucocorticoids on myogenic differentiation was reflected in the increased expression of muscle-specific genes, creatine kinase (CK) and acetylcholine receptor gamma subunit (AChR). Dexamethasone had no effect on CK and AChR mRNA stability and enhanced transcription from a CAT reporter genes containing the 3.3kb 5' flanking region of the murine CK gene (-3300MCK-CAT). Since dexamethasone did not affect the expression levels of the myogenic regulatory genes such as myoD and myogenin, the enhancement of muscle-specific transcription might reflect an increase in the functional activity of the regulatory proteins. Other possible mechanisms involved in the differentiation-enhancing effect of glucocorticoids are discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Line
  • Clone Cells / drug effects
  • Creatine Kinase / genetics
  • Dexamethasone / pharmacology*
  • Genes, Regulator*
  • Glucocorticoids / pharmacology*
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / drug effects*
  • MyoD Protein / genetics
  • Myogenin / genetics
  • Receptors, Cholinergic / genetics
  • Transcription, Genetic / drug effects*

Substances

  • Glucocorticoids
  • MyoD Protein
  • Myogenin
  • Receptors, Cholinergic
  • Dexamethasone
  • Creatine Kinase